The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Exosomes derived from mesenchymal stem cells attenuate inflammation and demyelination of the central nervous system in EAE rats by regulating the polarization of microglia
Abstract
Multiple sclerosis (MS) is a chronic demyelinating disease caused by central nervous system (CNS) inflammation and immune dysfunction, which often leaves patients with severe physical disabilities. Microglia function in the surveillance of the CNS, and an imbalance in the M1/M2 phenotypes of microglia contribute to the progression of MS. Recent studies indicate that exosomes secreted by bone marrow mesenchymal stem cells (BMSCs) play therapeutic roles in many autoimmune diseases and aid in tissue repair. However, it is not clear whether BMSC-derived exosomes can attenuate MS-associated inflammation and immune dysfunction, or how BMSC exosomes protect neurons. The experimental autoimmune encephalomyelitis (EAE) rat model was used to investigate the effect of exosomes on microglia polarization and inflammation in CNS. The results showed that exosome treatment significantly decreased neural behavioral scores, reduced the infiltration of inflammatory cells into the CNS, and decreased demyelination in comparison to untreated EAE rats. In addition, exosome treatment resulted in significant increases in the levels of M2-related cytokines such as interleukin (IL)-10 and transforming growth factor (TGF)-β, whereas M1-related tumor necrosis factor (TNF)-α and IL-12 levels decreased significantly. Moreover, compared with the untreated EAE group, the exosome group displayed significantly increased protein and mRNA expression levels of M2 phenotype markers, whereas M1 marker expression decreased. Our findings were further confirmed in an in vitro HAPI microglia cell line model. In conclusion, these findings indicate that BMSC-derived exosomes can attenuate inflammation and demyelination of the CNS in the EAE rat model by regulating the polarization of microglia. Therefore, the use of BMSC-derived exosomes may be a potential therapeutic approach for the treatment of autoimmune and inflammatory diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F. C., Krause, D. S., Deans, R. J., Keating, A., Prockop, D. J., & Horwitz, E. M. (2006) · Cytotherapy · doi:10.1080/14653240600855905 · Cited by 17,766
Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids
Théry, C., Amigorena, S., Raposo, G., & Clayton, A. (2006) · Current Protocols in Cell Biology · doi:10.1002/0471143030.cb0322s30 · Cited by 5,766
Exosomes – vesicular carriers for intercellular communication
Simons, M., & Raposo, G. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.03.007 · Cited by 2,351
Microglial M1/M2 polarization and metabolic states
Orihuela, R., McPherson, C. A., & Harry, G. J. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13139 · Cited by 2,070
Vlassov, A. V., Magdaleno, S., Setterquist, R., & Conrad, R. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.03.017 · Cited by 1,930
M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination
Miron, V. E., Boyd, A., Zhao, J.-W., Yuen, T. J., Ruckh, J. M., Shadrach, J. L., van Wijngaarden, P., Wagers, A. J., Williams, A., Franklin, R. J. M., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3469 · Cited by 1,777
Applying extracellular vesicles based therapeutics in clinical trials – an ISEV position paper
Lener, T., Gimona, M., Aigner, L., Börger, V., Buzas, E., Camussi, G., Chaput, N., Chatterjee, D., Court, F. A., del Portillo, H. A., et al. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.30087 · Cited by 1,491
Multiple Sclerosis: Mechanisms and Immunotherapy
Baecher-Allan, C., Kaskow, B. J., & Weiner, H. L. (2018) · Neuron · doi:10.1016/j.neuron.2018.01.021 · Cited by 938
Functions and mechanisms of microglia/macrophages in neuroinflammation and neurogenesis after stroke
Xiong, X.-Y., Liu, L., & Yang, Q.-W. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.05.001 · Cited by 701
Mesenchymal Stem Cells Secrete Immunologically Active Exosomes
Zhang, B., Yin, Y., Lai, R. C., Tan, S. S., Choo, A. B. H., & Lim, S. K. (2014) · Stem Cells and Development · doi:10.1089/scd.2013.0479 · Cited by 700
Exosomes for drug delivery—A novel application for the mesenchymal stem cell
Lai, R. C., Yeo, R. W. Y., Tan, K. H., & Lim, S. K. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2012.08.008 · Cited by 546
Chen, C.-Y., Rao, S.-S., Ren, L., Hu, X.-K., Tan, Y.-J., Hu, Y., Luo, J., Liu, Y.-W., Yin, H., Huang, J., et al. (2018) · Theranostics · doi:10.7150/thno.22958 · Cited by 380
Concise Review: Developing Best-Practice Models for the Therapeutic Use of Extracellular Vesicles
Reiner, A. T., Witwer, K. W., van Balkom, B. W. M., de Beer, J., Brodie, C., Corteling, R. L., Gabrielsson, S., Gimona, M., Ibrahim, A. G., de Kleijn, D., et al. (2017) · Stem Cells Translational Medicine · doi:10.1002/sctm.17-0055 · Cited by 345
Immunology of Relapse and Remission in Multiple Sclerosis
Steinman, L. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120227 · Cited by 330
Mokarizadeh, A., Delirezh, N., Morshedi, A., Mosayebi, G., Farshid, A.-A., & Mardani, K. (2012) · Immunology Letters · doi:10.1016/j.imlet.2012.06.001 · Cited by 320
Chu, F., Shi, M., Zheng, C., Shen, D., Zhu, J., Zheng, X., & Cui, L. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.02.015 · Cited by 303
Zaim, M., Karaman, S., Cetin, G., & Isik, S. (2012) · Annals of Hematology · doi:10.1007/s00277-012-1438-x · Cited by 294
Mesenchymal stem cells for clinical application
Sensebé, L., Krampera, M., Schrezenmeier, H., Bourin, P., & Giordano, R. (2010) · Vox Sanguinis · doi:10.1111/j.1423-0410.2009.01227.x · Cited by 258
Therapeutic Potential of Engineered Extracellular Vesicles
Mentkowski, K. I., Snitzer, J. D., Rusnak, S., & Lang, J. K. (2018) · The AAPS Journal · doi:10.1208/s12248-018-0211-z · Cited by 211
Li, Y., Yang, Y.-Y., Ren, J.-L., Xu, F., Chen, F.-M., & Li, A. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0648-5 · Cited by 207
Animal models of multiple sclerosis: Focus on experimental autoimmune encephalomyelitis
Bjelobaba, I., Begovic‐Kupresanin, V., Pekovic, S., & Lavrnja, I. (2018) · Journal of Neuroscience Research · doi:10.1002/jnr.24224 · Cited by 181
Wen, D., Peng, Y., Liu, D., Weizmann, Y., & Mahato, R. I. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.07.044 · Cited by 180
Mayourian, J., Ceholski, D. K., Gorski, P. A., Mathiyalagan, P., Murphy, J. F., Salazar, S. I., Stillitano, F., Hare, J. M., Sahoo, S., Hajjar, R. J., et al. (2018) · Circulation Research · doi:10.1161/circresaha.118.312420 · Cited by 168
Zhao, P., Xiao, L., Peng, J., Yq, Q., & Cc, H. (2018) · PubMed · doi:10.26355/eurrev_201806_15280 · Cited by 158
Tamura, R., Üemoto, S., & Tabata, Y. (2016) · Inflammation and Regeneration · doi:10.1186/s41232-016-0030-5 · Cited by 145
Multiple Sclerosis Pathology: Evolution of Pathogenetic Concepts
Lassmann, H. (2005) · Brain Pathology · doi:10.1111/j.1750-3639.2005.tb00523.x · Cited by 132
Wang, Y., Zhao, R., Liu, D., Deng, W., Xu, G., Liu, W., Rong, J., Long, X., Ge, J., & Shi, B. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/4971261 · Cited by 108
Ouyang, X., Han, X., Chen, Z., Fang, J., Huang, X., & Wei, H. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-1003-1 · Cited by 101
Xiao, Y., Geng, F., Wang, G., Li, X., Zhu, J., & Zhu, W.-J. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27519 · Cited by 98
Xu, C., Fu, F., Li, X., & Zhang, S. (2017) · International Journal of Neuroscience · doi:10.1080/00207454.2017.1325884 · Cited by 78
Kubota, K., Nakano, M., Kobayashi, E., Mizue, Y., Chikenji, T., Otani, M., Nagaishi, K., & Fujimiya, M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0204252 · Cited by 78
Nessler, J. N., Bénardais, K., Gudi, V., Hoffmann, A., Tejedor, L. S., Janßen, S., Prajeeth, C. K., Baumgärtner, W., Kavelaars, A., Heijnen, C. J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069795 · Cited by 51
The Immunoregulatory Activity of Mesenchymal Stem Cells: ‘State of Art’ and ‘Future Avenues’
Fierabracci, A., Fattore, A. D., & Muraca, M. (2016) · Current Medicinal Chemistry · doi:10.2174/0929867323666160627112827 · Cited by 46
Yang, X., Yan, J., & Feng, J. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.12.014 · Cited by 43
Self-citationYang, H., Liu, C., Jiang, J., Wang, Y., & Zhang, X. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00044 · Cited by 43
He, X., Yuan, W., Li, Z., Hou, Y., Liu, F., & Feng, J. (2017) · Toxicology Letters · doi:10.1016/j.toxlet.2017.11.017 · Cited by 41
Self-citationEl–Akabawy, G., & Rashed, L. A. (2015) · Annals of Anatomy - Anatomischer Anzeiger · doi:10.1016/j.aanat.2014.12.002 · Cited by 40
Gao, S., Zhao, Z., Wu, R., Zeng, Y., Zhang, Z., Miao, J., & Yuan, Z. (2016) · Radiation and Environmental Biophysics · doi:10.1007/s00411-016-0675-0 · Cited by 34
Endogenously regulated Dab2 worsens inflammatory injury in experimental autoimmune encephalomyelitis
Jokubaitis, V. G., Gresle, M. M., Kemper, D. A., Doherty, W., Perreau, V. M., Cipriani, T. L., Jonas, A., Shaw, G., Kuhlmann, T., Kilpatrick, T. J., et al. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-32 · Cited by 31
The potential role of exosomes in the diagnosis and therapy of ischemic diseases
Wang, W., Li, Z., & Feng, J. (2018) · Cytotherapy · doi:10.1016/j.jcyt.2018.06.012 · Cited by 27
Self-citationMokarizadeh, A., Delirezh, N., Morshedi, A., Mosayebi, G., Farshid, A.-A., & Dalir‐Naghadeh, B. (2012) · Europe PMC (PubMed Central) · Cited by 25
Bowles, A. C., Scruggs, B. A., & Bunnell, B. A. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-1453-1_25 · Cited by 22
Cited by
Microglia polarization from M1 to M2 in neurodegenerative diseases
Guo, S., Wang, H., & Yin, Y. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.815347 · Cited by 920
Clinical applications of stem cell-derived exosomes
Tan, F., Li, X., Wang, Z., Li, J., Shahzad, K., & Zheng, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01704-0 · Cited by 708
Harrell, C., Fellabaum, C., Jovicic, N., Djonov, V., Arsenijevic, N., & Volarevic, V. (2019) · Cells · doi:10.3390/cells8050467 · Cited by 501
Brennan, M. Á., Layrolle, P., & Mooney, D. J. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201909125 · Cited by 396
Bian, D., Wu, Y., Song, G., Azizi, R., & Zamani, A. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02697-9 · Cited by 370
Metadata
- Authors
- Li, Z., Liu, F., He, X., Yang, X., Shan, F., & Feng, J.
- Venue
- International Immunopharmacology
- Publisher
- Elsevier BV
- Published
- 2019-02
- Volume
- 67
- Pages
- 268-280
- ISSN
- 1567-5769 (ISSN-L)
- OpenAlex
- W2904668262
- Cited by
- 277
- References
- 42
- FWCI
- 6.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.